Both medications are fully approved in the UK for the treatment of obesity
Patients are "better served" by an expert, such as a weight-loss physician or primary care doctor, who can closely monitor them while taking these drugs, the doctor suggested, especially with the risk of certain side effects, like nausea or pancreatitis
The most common side effects reported with GLP-1 receptor agonists include nausea, vomiting, constipation, and mild digestive discomfort, particularly during the dose escalation phase
The early data is impressive, especially considering its a pill and not an injection
It has been implicated in cytokine production, which regulates immune response and promotes anti-inflammatory pathways